Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases
Schmidt, K.L.
Journal of Rheumatology 27(9): 2281-2282
2000
ISSN/ISBN: 0315-162X PMID: 10990251 Document Number: 517528
Document emailed within 1 workday
Related Documents
Kokot, T.; Muc-Wierzgoń, M.; Zubelewicz, B.; Wierzgoń, J.; Nowakowska, E.; Brodziak, A. 2000: Soluble tumor necrosis factor receptors--their properties and role in diagnosis and therapy of acute and chronic diseases Postepy Higieny i Medycyny Doswiadczalnej 54(5): 585-596Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Krichevskaia, O.A.; Kliukvina, N.G.; Aleksandrova, E.N.; Samsonov, M.I.; Nasonov, E.L. 2004: Clinical value of soluble tumor necrosis factor-alpha receptors in patients with systemic lupus erythematosus Klinicheskaia Meditsina 82(10): 51-55
Kacprzyk, F. 2002: Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis Polskie Archiwum Medycyny Wewnetrznej 107(3): 215-221
García, M.Martin.; De Rissio, A.Maria.; Villalonga, X.; Mengoni, E.; Cardoni, R.L. 2008: Soluble tumor necrosis factor (TNF) receptors (sTNF-R1 and -R2) in pregnant women chronically infected with Trypanosoma cruzi and their children American Journal of Tropical Medicine and Hygiene 78(3): 499-503
Sorkine, P.; Setton, A.; Halpern, P.; Miller, A.; Rudick, V.; Marmor, S.; Klausner, J.M.; Goldman, G. 1995: Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration Critical Care Medicine 23(8): 1377-1381
Ohno, S.; Strebel, F.R.; Stephens, L.C.; Siddik, Z.H.; Makino, M.; Klostergaard, J.; Tomasovic, S.P.; Khokhar, A.R.; Bull, J.M. 1992: Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats Cancer Research 52(15): 4096-4101
Mohler, K.M.; Torrance, D.S.; Smith, C.A.; Goodwin, R.G.; Stremler, K.E.; Fung, V.P.; Madani, H.; Widmer, M.B. 1993: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists Journal of Immunology 151(3): 1548-1561
Tziakas, D.; Chalikias, G.; Parissis, J.T.; Hatzinikolaou, H.; Stakos, D.; Papadopoulou, E.; Kortsaris, A.; Hatseras, D. 2004: Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3 European Cytokine Network 15(3): 231-239
Sundrarjun, T.; Komindr, S.; Archararit, N.; Dahlan, W.; Puchaiwatananon, O.; Angthararak, S.; Udomsuppayakul, U.; Chuncharunee, S. 2004: Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis Journal of International Medical Research 32(5): 443-454
Flood, J. 2009: Tumor necrosis factor inhibitors in the treatment of chronic inflammatory diseases. a review of immunogenicity and potential implications Managed Care 18(4 Suppl 3: 1-5
Kristiansson, M.; Soop, M.; Shanwell, A.; Sundqvist, K.G. 1996: Prestorage versus bedside white blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors Journal of Trauma 40(3): 379-383
Nassonov, E.L.; Samsonov, M.Y.; Tilz, G.P.; Beketova, T.V.; Semenkova, E.N.; Baranov, A.; Wachter, H.; Fuchs, D. 1997: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis Journal of Rheumatology 24(4): 666-670
Takemura, M.; Saito, K.; Seishima, M. 2005: Soluble tumor necrosis factor receptor I, Ii Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 158-160
Scheurich, P.; Thoma, B.; Ucer, U.; Pfizenmaier, K. 1987: Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses Journal of Immunology 138(6): 1786-1790
Pfeffer, K. 2000: Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands European Cytokine Network 11(3): 514
Radhakrishnan, V.V.; Sumi, M.G.; Reuben, S.; Mathai, A.; Nair, M.D. 2003: Circulating tumour necrosis factor alpha and soluble TNF receptors in patients with Guillain-Barre syndrome Indian Journal of Medical Research 117: 216-220
Tamura, K.; Ishida, N. 1984: Induction of tumor necrosis factor (TNF) in tumor-bearing mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1369-1378
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653